Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Innovative 'Health to Go' vending machine in Millersburg offers free naloxone, drug checking strips, and health supplies while connecting users to community services through an interactive touchscreen interface.
Kentucky's Opioid Abatement Advisory Commission announces largest settlement distribution yet, funding prevention, treatment, and recovery programs across the state.
Togus VA Medical Center opens Maine's first residential substance use disorder program for veterans, ending years of out-of-state travel for inpatient care.
Agency accelerates regulatory action on psilocybin, methylone, and noribogaine following Trump executive order, issuing priority vouchers and clearing Phase 1 studies.
In a historic first, the FDA clears DemeRx's noribogaine hydrochloride for Phase I study, marking the first US clinical trial of an ibogaine-derived compound for addiction treatment.
Tens of thousands of individuals harmed by OxyContin will receive nothing from Purdue's $7.4 billion bankruptcy settlement after strict eligibility changes and documentation requirements.
State Department deploys economic sanctions against sophisticated supply chain providing precursor chemicals to Sinaloa Cartel, implementing Executive Order designating fentanyl as Weapon of Mass Destruction.
Leaked details reveal DEA plans to limit telehealth prescriptions for controlled substances, requiring 50% in-person visits and affecting buprenorphine access for opioid use disorder treatment.
Study of 600,000 U.S. veterans finds GLP-1 drugs like Ozempic and Wegovy associated with dramatic reductions in substance use disorder complications, overdoses, and deaths.